U.S. Markets closed
  • S&P Futures

    3,902.00
    +4.25 (+0.11%)
     
  • Dow Futures

    31,241.00
    +39.00 (+0.12%)
     
  • Nasdaq Futures

    11,838.00
    -40.25 (-0.34%)
     
  • Russell 2000 Futures

    1,771.50
    -3.40 (-0.19%)
     
  • Crude Oil

    110.35
    +0.46 (+0.42%)
     
  • Gold

    1,845.10
    +3.90 (+0.21%)
     
  • Silver

    21.87
    -0.03 (-0.13%)
     
  • EUR/USD

    1.0562
    -0.0026 (-0.2429%)
     
  • 10-Yr Bond

    2.7870
    -0.0680 (-2.38%)
     
  • Vix

    29.43
    +0.08 (+0.27%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.1587%)
     
  • USD/JPY

    127.8500
    +0.0560 (+0.0438%)
     
  • BTC-USD

    30,133.69
    +746.85 (+2.54%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

Chemours (CC) Earnings and Revenues Surpass Estimates in Q3

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The Chemours Company CC posted a profit of $214 million or $1.27 per share in the third quarter of 2021, up from a profit of $76 million or 46 cents in the year-ago quarter. Earnings per share topped the Zacks Consensus Estimate of 99 cents.

Net sales increased around 36% year over year to $1,680 million. The top line beat the Zacks Consensus Estimate of $1,638 million. An unfavorable 1% portfolio impact from the exit of the aniline business was more than offset by 25% volume growth, 11% higher pricing and 1% favorable currency translation. Sales rose 2% on a sequential basis on strengthening pricing across the portfolio.

The Chemours Company Price, Consensus and EPS Surprise

The Chemours Company Price, Consensus and EPS Surprise
The Chemours Company Price, Consensus and EPS Surprise

The Chemours Company price-consensus-eps-surprise-chart | The Chemours Company Quote

Segment Highlights

The Titanium Technologies division logged in revenues of $908 million in the quarter, up around 48% year over year. Volumes rose 33% year over year owing to strong demand in all regions and end markets.

Revenues in the Thermal & Specialized Solutions segment scaled up 9% year over year to $318 million in the reported quarter. Volumes increased 1% year over year as strong demand in refrigerants across most regions was offset by constrained automotive demand. Moreover, the company witnessed Opteon adoption across all markets amid headwinds from semiconductor supply-chain disruptions that impacted automotive demand.

Revenues in the Advanced Performance Materials unit were $356 million, up roughly 48% year over year. The increase in year-over-year sales was driven by demand recovery across nearly all end markets and regions, despite raw material availability issues. Volume increase and price increase contributed 38% and 8%, respectively, to the year-over-year sales performance.

The Chemical Solutions unit recorded sales of $98 million, up 11% year over year. Volume increase and price increase contributed 14% and 15%, respectively, to the year-over-year sales performance, partly offset by portfolio changes. The company witnessed a strong performance in Glycolic Acid and Mining solutions.

Financials

Chemours ended the quarter with cash and cash equivalents of $1,031 million, increasing roughly 7.8% year over year. Long-term debt was $3,829 million, down around 5.8% year over year.

Cash provided by operating activities was $311 million for the third quarter. Free cash flow for the quarter was $244 million.

The company also bought back common stock worth $67 million during the quarter.

Outlook

Chemours raised its expectations for full-year 2021 on the back of its strong third-quarter performance. It now sees adjusted EBITDA within a range of $1,300-$1,340 million compared with the prior guidance in the top-end of $1,100-$1,250 million range.

The company also expects adjusted earnings per share in the band of $3.93-$4.13 compared with the prior guidance in the top-end of $2.84-$3.56 range.

Free cash flow for 2021 is now forecast to be more than $500 million, up from prior guidance of more than $450 million.

Price Performance

Shares of Chemours have gained 26.4% in the past year, outperforming the industry’s growth of 25.4%.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Zacks Rank & Stocks to Consider

Currently, Chemours carries a Zacks Rank #2 (Buy).

Other top-ranked stocks worth considering in the basic materials space include Nutrien Ltd. NTR, Steel Dynamics, Inc. STLD and Methanex Corporation MEOH, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Nutrien has an expected earnings growth rate of 181.7% for the current year. The stock has also rallied around 66% over a year.

Steel Dynamics has a projected earnings growth rate of 477.5% for the current year. The company’s shares have surged around 99% in a year.

Methanex has a projected earnings growth rate of 453.7% for the current year. The company’s shares have shot up around 53% in a year.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Steel Dynamics, Inc. (STLD) : Free Stock Analysis Report

Methanex Corporation (MEOH) : Free Stock Analysis Report

The Chemours Company (CC) : Free Stock Analysis Report

Nutrien Ltd. (NTR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research